Redmile Group as of March 31, 2018
Portfolio Holdings for Redmile Group
Redmile Group holds 64 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 10.8 | $281M | 17M | 16.32 | |
| Atara Biotherapeutics | 6.4 | $165M | 4.2M | 39.00 | |
| Amicus Therapeutics (FOLD) | 6.2 | $162M | 11M | 15.04 | |
| ImmunoGen | 3.9 | $102M | 9.7M | 10.52 | |
| Xencor (XNCR) | 3.7 | $96M | 3.2M | 29.98 | |
| Wave Life Sciences (WVE) | 3.5 | $90M | 2.2M | 40.10 | |
| Alder Biopharmaceuticals | 3.2 | $83M | 6.5M | 12.70 | |
| Avexis | 3.0 | $79M | 637k | 123.58 | |
| Puma Biotechnology (PBYI) | 2.9 | $75M | 1.1M | 68.05 | |
| WellCare Health Plans | 2.6 | $66M | 342k | 193.63 | |
| Abbott Laboratories (ABT) | 2.5 | $66M | 1.1M | 59.92 | |
| Fate Therapeutics (FATE) | 2.5 | $65M | 6.7M | 9.76 | |
| Regenxbio Inc equity us cm (RGNX) | 2.5 | $64M | 2.1M | 29.85 | |
| Penumbra (PEN) | 2.4 | $63M | 547k | 115.65 | |
| Centene Corporation (CNC) | 2.3 | $60M | 560k | 106.87 | |
| Anaptysbio Inc Common (ANAB) | 2.1 | $54M | 523k | 104.08 | |
| Syneos Health | 2.1 | $54M | 1.5M | 35.50 | |
| ICU Medical, Incorporated (ICUI) | 1.9 | $49M | 194k | 252.40 | |
| Insmed (INSM) | 1.9 | $49M | 2.2M | 22.52 | |
| Livanova Plc Ord (LIVN) | 1.8 | $46M | 518k | 88.50 | |
| Irhythm Technologies (IRTC) | 1.8 | $46M | 730k | 62.95 | |
| Bluebird Bio | 1.8 | $46M | 267k | 170.75 | |
| Teleflex Incorporated (TFX) | 1.7 | $45M | 177k | 254.98 | |
| Alexion Pharmaceuticals | 1.7 | $45M | 405k | 111.46 | |
| Audentes Therapeutics | 1.5 | $39M | 1.3M | 30.05 | |
| Cymabay Therapeutics | 1.5 | $38M | 3.0M | 12.99 | |
| Glycomimetics | 1.4 | $37M | 2.3M | 16.23 | |
| Epizyme | 1.4 | $36M | 2.0M | 17.75 | |
| UnitedHealth (UNH) | 1.2 | $31M | 145k | 214.00 | |
| Oxford Immunotec Global | 1.2 | $31M | 2.5M | 12.45 | |
| Jounce Therapeutics | 1.0 | $26M | 1.2M | 22.35 | |
| Nightstar Therapeutics | 1.0 | $25M | 1.8M | 14.37 | |
| Array Biopharma Inc bond | 1.0 | $25M | 19M | 1.33 | |
| Endologix | 1.0 | $25M | 5.9M | 4.23 | |
| Inflarx Nv (IFRX) | 0.9 | $25M | 851k | 28.84 | |
| Alder Biopharmaceuticals Inc convertible security | 0.9 | $23M | 25M | 0.92 | |
| Syros Pharmaceuticals | 0.8 | $21M | 1.7M | 12.98 | |
| Pra Health Sciences | 0.8 | $20M | 245k | 82.96 | |
| Allscripts Healthcare Solutions (MDRX) | 0.8 | $20M | 1.6M | 12.35 | |
| Chimerix (CMRX) | 0.8 | $19M | 3.7M | 5.20 | |
| eHealth (EHTH) | 0.7 | $19M | 1.3M | 14.31 | |
| Argenx Se (ARGX) | 0.7 | $19M | 239k | 80.44 | |
| Heska Corporation | 0.7 | $19M | 238k | 79.07 | |
| Deciphera Pharmaceuticals | 0.6 | $17M | 821k | 20.04 | |
| Mylan Nv | 0.6 | $16M | 381k | 41.17 | |
| Newlink Genetics Corporation | 0.6 | $15M | 2.1M | 7.25 | |
| Odonate Therapeutics Ord | 0.5 | $13M | 594k | 21.18 | |
| Teladoc (TDOC) | 0.4 | $11M | 273k | 40.30 | |
| Armo Biosciences Ord | 0.4 | $11M | 299k | 37.41 | |
| Invitae (NVTAQ) | 0.4 | $10M | 2.1M | 4.69 | |
| Model N (MODN) | 0.4 | $9.5M | 524k | 18.05 | |
| Cytomx Therapeutics (CTMX) | 0.4 | $9.5M | 335k | 28.45 | |
| Universal Health Services (UHS) | 0.3 | $8.0M | 68k | 118.41 | |
| Beigene (ONC) | 0.3 | $6.7M | 40k | 168.00 | |
| Petiq (PETQ) | 0.2 | $5.2M | 197k | 26.60 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.2 | $5.0M | 1.9M | 2.65 | |
| Aclaris Therapeutics (ACRS) | 0.1 | $1.9M | 107k | 17.52 | |
| Ovid Therapeutics (OVID) | 0.0 | $1.1M | 161k | 7.07 | |
| Accuray Incorporated (ARAY) | 0.0 | $145k | 29k | 5.00 | |
| iShares Dow Jones US Health Care (IHF) | 0.0 | $330k | 2.1k | 158.12 | |
| EXACT Sciences Corporation (EXAS) | 0.0 | $328k | 8.1k | 40.34 | |
| Flexion Therapeutics | 0.0 | $223k | 9.9k | 22.46 | |
| Horizon Pharma | 0.0 | $284k | 20k | 14.20 | |
| Adverum Biotechnologies | 0.0 | $129k | 22k | 5.80 |
